AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $4.91M invested in AIM ImmunoTech in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.69M
2
+$1.65M
3
+$16.4K
4
PAM
Panagora Asset Management
Massachusetts
+$14K
5
Renaissance Technologies
Renaissance Technologies
New York
+$11.1K

Top Sellers

1
-$10K
2
-$9K
3
-$8K
4
Citadel Advisors
Citadel Advisors
Florida
-$5K
5
TCM
Traynor Capital Management
Pennsylvania
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.69M
2
$1.65M
3
$604K
4
$581K
5
$199K
6
$93K
7
$21K
8
$20K
9
$14K
10
$13K
11
$7K
12
$7K
13
$4K
14
$1K
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–